SAN DIEGO, June 26 /PRNewswire/ -- AVANIR Pharmaceuticals (Amex: AVN)
today announced that Gerald J. Yakatan, Ph.D., President and Chief Executive
Officer will appear as a guest on AOL's (NYSE: AOL) MarketTalk produced by
Sage Online (AOL Keyword: MarketTalk) on Wednesday, June 27, 2001 at 1:00 p.m.
EDT. The live event will last for 20 minutes, throughout which Dr. Yakatan
will answer questions posted live from the Sage Online audience
(for AOL members only).
Sage Online is a subsidiary of Multex.com, the Internet's leading
financial e-marketplace connecting buyers and sellers of financial services
and information. Sage was founded by Co-Presidents Alan and Stephen Cohn, who
were recognized by the Wall Street Journal and SmartMoney magazine as one of
the top 10 most influential forces in the mutual fund industry. Alan and
Stephen are authors of the book "The Sage Guide to Mutual Funds."
As previously announced, AVANIR Pharmaceuticals is participating in the
BIO2001 International Biotechnology Convention being held this week in San
Diego. Today, June 26, Dr. Yakatan is speaking at the Investor and Partnering
Forum where an overview of the Company will be provided to potential investors
and corporate partners.
A live webcast of the Investor and Partnering Forum presentation will be
available to the public via the Internet today at 8:30 a.m. PDT. To view the
webcast, go to:
http://www.informedinvestors.com/iif_forums/event.cfm?forumlD=178. The
presentation will be archived for 90 days following the event and may also be
accessed from AVANIR's corporate website at http://www.avanir.com.
About AVANIR Pharmaceuticals
AVANIR Pharmaceuticals, based in San Diego, is an emerging diversified
biopharmaceutical company engaged in research, development, commercialization,
licensing and sales of innovative drug products and antibody generation
services. The Company's website is http://www.avanir.com.
SOURCE AVANIR Pharmaceuticals
 back to top
Related links:
http://www.avanir.com
Company News On-Call:
http://www.prnewswire.com/comp/157196.html or fax,
800-758-5804, ext. 157196
CONTACT:
Kristen Kopay, General Information,
310-996-7458, kmkopay@bsmg.com, or Tricia Ross, Analyst/Investor,
310-996-7454, tross@bsmg.com, or Haris Tajyar, Media,
310-996-7462, htajyar@bsmg.com, all of The Financial Relations
Board BSMG Worldwide, for AVANIR Pharmaceuticals; or Patrice
Saxon, Investor Relations of AVANIR Pharmaceuticals, 858-622-5202
|
